Brief: Century Therapeutics Reports Third Quarter 2023 Financial Results And Provides Business Updates
09/11/2023 12:41
Nov 9 (Reuters) - Century Therapeutics Inc IPSC.O :
* CENTURY THERAPEUTICS REPORTS THIRD QUARTER 2023 FINANCIAL
RESULTS AND PROVIDES BUSINESS UPDATES
* CENTURY THERAPEUTICS INC - ENDED Q3 2023 WITH CASH, CASH
EQUIVALENTS, AND INVESTMENTS OF $284.3 MILLION; CASH RUNWAY INTO
2026
* CENTURY THERAPEUTICS INC: EXPECTS FULL YEAR GAAP OPERATING
EXPENSES TO BE BETWEEN $135 MILLION AND $145 MILLION
Source text for Eikon: ID:nGNX5cHxY
Further company coverage: IPSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Century Therapeutics
See all newsCentury Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Century Therapeutics Q2 net loss misses estimates on lease termination loss
Brief: Century Therapeutics Q2 Net Income USD -34.55 Million Vs. IBES Estimate USD -22.4 Million
Century Therapeutics, Inc. expected to post a loss of 11 cents a share - Earnings Preview
Century Therapeutics Inc expected to post a loss of 11 cents a share - Earnings Preview